Expression of nerve growth factor and matrix metallopeptidase-9/tissue inhibitor of metalloproteinase-1 in asthmatic patients

Journal of Asthma

Volumn 50, Issue 7, 2013, Pages 712-717

  Kim, Ju Sang ^a   Kang, Ji Young ^a   Ha, Jick Hwan ^a   Lee, Hea Yeon ^a   Kim, Seung Joon ^a   Kim, Seok Chan ^a   Ahn, Joong Hyun ^a   Kwon, Soon Seog ^a   Kim, Young Kyoon ^a   Lee, Sook Young ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

MMP 9; Nerve growth factor; TIMP 1

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; NERVE GROWTH FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; INTERLEUKIN DERIVATIVE;

ADULT; ARTICLE; ASTHMA; BRONCHITIS; BRONCHOSCOPY; BRONCHUS MUCOSA; CLINICAL ARTICLE; COUGHING; EOSINOPHIL; FEMALE; FORCED VITAL CAPACITY; GASTROESOPHAGEAL REFLUX; HUMAN; LUNG CANCER; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; PNEUMONIA; TH2 CELL; ADOLESCENT; AGED; BIOSYNTHESIS; BLOOD; CHEMISTRY; CYTOLOGY; ENZYMOLOGY; EOSINOPHILIA; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; EOSINOPHILIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKINS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NERVE GROWTH FACTOR; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; STATISTICS, NONPARAMETRIC; TISSUE INHIBITOR OF METALLOPROTEINASE-1; YOUNG ADULT;

EID: 84883636957     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2013.808664     Document Type: Article

References (31)

1. Nockher WA, Renz H. Neurotrophins in allergic diseases: from neuronal growth factors to intercellular signaling molecules. J Allergy Clin Immunol 2006;117:5835-5889.
2. Bonini S, Lambiase A, Bonini S, Angelucci F, Magrini L, Manni L, Aloe L. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci USA 1996;93:10955-10960.
3. Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002;147:717-719.
4. Kassel O, de Blay F, Duvernelle C, Olgart C, Israel-Biet D, Krieger P, Moreau L, et al. Local increase in the number of mast cells and expression of nerve growth factor in the bronchus of asthmatic patients after repeated inhalation of allergen at low-dose. Clin Exp Allergy 2001;31:1432-1440.
5. Olgart Höglund C, de Blay F, Oster JP, Duvernelle C, Kassel O, Pauli G, Frossard N. Nerve growth factor levels and localisation in human asthmatic bronchi. Eur Respir J 2002;20:1110-1116.
6. Nassenstein C, Schulte-Herbrüggen O, Renz H, Braun A. Nerve growth factor: the central hub in the development of allergic asthma? Eur J Pharmacol 2006;533:195-206.
7. Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 2003;28:12-24.
8. Cataldo DD, Bettiol J, Noël A, Bartsch P, Foidart JM, Louis R. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest 2002;122:1553-1559.
9. Bossé M, Chakir J, Rouabhia M, Boulet LP, Audette M, Laviolette M. Serum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma. Am J Respir Crit Care Med 1999;159: 596-602.
10. Micera A, Vigneti E, Pickholtz D, Reich R, Pappo O, Bonini S, Maquart FX, et al. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci USA 2001;98: 6162-6167.
11. Freund-Michel V, Bertrand C, Frossard N. TrkA signaling pathways in human airway smooth muscle cell proliferation. Cell Signal 2006;18:621-627.
12. Dagnell C, Kemi C, Klominek J, Eriksson P, Sköld CM, Eklund A, Grunewald J, et al. Effects of neurotrophins on human bronchial smooth muscle cell migration and matrix metalloproteinase-9 secretion. Transl Res 2007;150:303-310.
13. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136.
14. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-244.
15. Nockher WA, Renz H. Neurotrophins and asthma: novel insight into neuroimmune interaction. J Allergy Clin Immunol 2006;117: 67-71.
16. Nadel JA. Neutral endopeptidase modulates neurogenic inflammation. Eur Respir J 1991;4:745-754.
17. Nassenstein C, Braun A, Erpenbeck VJ, Lommatzsch M, Schmidt S, Krug N, Luttmann W, et al. The neurotrophins nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 are survival and activation factors for eosinophils in patients with allergic bronchial asthma. J Exp Med 2003;198: 455-467.
18. Solomon A, Aloe L, Pe'er J, Frucht-Pery J, Bonini S, Levi-Schaffer F. Nerve growth factor is performed in and activates human peripheral blood eosinophils. J Allergy Clin Immunol 1998;102: 454-460.
19. Kobayashi H, Gleich GJ, Butterfield JH, Kita H. Human eosinophil produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood 2002;99:2214-2220.
20. Raap U, Deneka N, Bruder M, Kapp A, Wedi B. Differential upregulation of neurotrophin receptors and functional activity of neurotrophins on peripheral blood eosinophils of patients with allergic rhinitis, atopic dermatitis and nonatopic subjects. Clin Exp Allergy 2008;38:1493-1498.
21. O'Connor TM, O'Connor J, O'Brian DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol 2004;201:167-180.
22. Lindsay RM, Harmar AJ. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 1989;337: 362-364.
23. Päth G, Braun A, Meents N, Kerzel S, Quarcoo D, Raap U, Hoyle GW, et al. Augmentation of allergic early-phase reaction by nerve growth factor. Am J Respir Crit Care Med 2002;166:818-826.
24. Kerzel S, Päth G, Nockher WA, Quarcoo D, Raap U, Groneberg DA, Dinh QT, et al. Pan-neurotrophin receptor p75 contributes to neuronal hyperreactivity and airway inflammation in a murine model of experimental asthma. Am J Respir Cell Mol 2003;28: 170-178.
25. Hoyle GW, Graham RM, Finkelstein JB, Nguyen KPT, Gozal D, Friedman M. Hyperinnervation of the airways in transgenic mice overexpressing nerve growth factor. Am J Respir Cell Mol Biol 1998;18:149-157.
26. Gueders MM, Foidart JM, Noel A, Cataldo DD. Matric metalloproteinases (MMPs) and tissue inhibitor of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur J Pharmacol 2006;533:133-144.
27. Ogawa H, Azuma M, Uehara H, Takahashi T, Nishioka Y, Sone S, Izumi K. Nerve growth factor derived from bronchial epithelium after chronic mite antigen exposure contributes to airway hyperresponsiveness by inducing hyperinnervation, and is inhibited by in vivo siRNA. Clin Exp Allergy 2012;42:460-470.
28. Calikoglu M, Unlü A, Tamer L, Ozgür E. MMP-9 and TIMP-1 levels in the sputum of patients with chronic obstructive pulmonary disease and asthma. Tuberk Toraks 2006;54:114-121.
29. Ko FW, Diba C, Roth M, McKay K, Johnson PR, Salome C, King GG. A comparison of airway and serum matrix metalloproteinase-9 activity among normal subjects, asthmatic patients, and patients with asthmatic mucus hypersecretion. Chest 2005;127:1919-1927.
30. Sands MF, Ohtake PJ, Mahajan SD, Takyar SS, Aalinkeel R, Fang YV, Blume JW, et al. Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma. Clin Immunol 2009;130:186-198.
31. Khan KM, Falcone DJ, Kraemer R. Nerve growth factor activation of Erk-1 and Erk-2 induces matrix metalloproteinase-9 expression in vascular smooth muscle cells. J Biol Chem 2002; 277:2353-2359.